DSIP (Delta Sleep-Inducing Peptide)
A sleep peptide with a compelling name but a surprisingly thin, decades-old evidence base. One to be upfront about.
What is DSIP?
DSIP, or delta sleep-inducing peptide, is a naturally occurring nine-amino-acid peptide first isolated decades ago from the blood of sleeping rabbits. As the name suggests, it is studied for promoting sleep. It is an intriguing but genuinely uncertain compound: despite a long research history, the data is inconsistent and the mechanism is still not well understood.
How DSIP works
This is an unusually honest section, because the truth is that DSIP's mechanism is unclear. It is thought to influence sleep regulation and stress and hormonal systems, but researchers have not pinned down a clean pathway the way they have for many other compounds. It does appear to be able to cross into the brain, but exactly how it would promote deeper or delta-wave sleep remains an open question.
What the research shows
The clinical record is mixed and thin. Some human studies reported improvements in objective sleep measures like sleep efficiency and time to fall asleep. But a double-blind study in patients with chronic insomnia concluded that short-term DSIP treatment was unlikely to be of major therapeutic benefit. Taken together, the high-quality human evidence is limited and somewhat contradictory, which is why DSIP sits in a gray zone rather than as an established sleep aid.
Dosage and how it is used
There is no approved or standardized dose. Community protocols use subcutaneous injection, often before bed, but the figures are not grounded in modern dose-finding trials. Given the inconsistent efficacy data, any protocol should be seen as experimental.
→ How to reconstitute DSIP: calculator, units to draw & storage
Side effects and safety
DSIP has generally been described as well tolerated in the limited studies available, but there is little high-quality human safety data, especially for repeated self-use. As with other research peptides, unregulated sourcing adds purity uncertainty, and the weak efficacy evidence means expectations should be low.
- Research depth: limited and inconsistent. Mechanism poorly understood.
- Mixed human sleep data; little high-quality long-term safety information.
- Not FDA-approved. Verify current legal and regulatory status independently.
Frequently asked questions
Does DSIP actually improve sleep?
The evidence is mixed and limited. Some studies report better sleep efficiency and faster sleep onset, but a double-blind study in chronic insomnia concluded it was unlikely to offer major benefit. High-quality human data is sparse.
How does DSIP work?
Honestly, the mechanism is not well understood. DSIP is a naturally occurring nonapeptide first isolated from sleeping animals, and despite decades of study its exact sleep-promoting pathway remains unclear.
Is DSIP well studied?
No. The research is old, inconsistent, and small, with limited high-quality human safety and efficacy data. It is one of the more uncertain compounds in the sleep space.
Is DSIP FDA-approved?
No. It is a research peptide, not an approved sleep medication, and its legal status varies by jurisdiction.
References
Track DSIP (Delta Sleep-Inducing Peptide) in Peptide AI
Log your doses, connect labs and wearables, and let the AI show you how DSIP (Delta Sleep-Inducing Peptide) is affecting your biomarkers over time.
Download the appEducational information only. This is not medical advice. Peptide AI is an informational and tracking platform. Everything on this page is for general education. It is not a substitute for professional medical advice and is not a recommendation to use any compound. Many peptides listed here are research compounds the FDA has not approved for human use. Talk to a qualified, licensed healthcare provider before you start, change, or stop any protocol.